Properties (61)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Acquired_by_AstraZeneca_in_2007
|
| gptkbp:CEO |
gptkb:Yasushi_Saito
|
| gptkbp:clinicalTrials |
Conducts clinical trials
Conducts healthcare research Analyzes clinical trial outcomes Conducts trials in various phases Focuses on biopharmaceuticals Focuses on patient centricity Follows clinical guidelines Involved in drug development processes Recruits clinical trial participants Shares clinical data with stakeholders Conducts_clinical_research_in_Japan Operates_clinical_trial_locations_in_Japan |
| gptkbp:collaborations |
Collaborates with local institutions
|
| gptkbp:community_service |
Provides resources for healthcare professionals
Promotes healthcare collaboration Works to improve healthcare access |
| gptkbp:communityEngagement |
Engages in community health initiatives
|
| gptkbp:communityPartnerships |
Establishes healthcare partnerships
|
| gptkbp:corporateSocialResponsibility |
Engages in corporate social responsibility initiatives
|
| gptkbp:drugInterdiction |
Facilitates drug approval processes
Maintains a drug development pipeline Monitors drug safety |
| gptkbp:employees |
Approximately 1,500
|
| gptkbp:focus |
Immunology
Oncology Cardiovascular Respiratory Rare diseases |
| gptkbp:founded |
2007
|
| gptkbp:globalPresence |
Part of a global pharmaceutical company
|
| gptkbp:hasCapacity |
Offers patient support programs
|
| gptkbp:headquarters |
gptkb:Tokyo,_Japan
|
| gptkbp:healthcare |
Supports patient advocacy groups
Aims to improve health outcomes Provides patient education resources Drives healthcare innovation Enhances patient care services Improves healthcare quality Prioritizes patient safety |
| https://www.w3.org/2000/01/rdf-schema#label |
AstraZeneca Japan K.K.
|
| gptkbp:impact |
Engages in therapeutic research
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:innovation |
Invests in innovative therapies
|
| gptkbp:market |
Strong_presence_in_Japan
|
| gptkbp:partnerships |
Forms partnerships with healthcare providers
|
| gptkbp:partOf |
AstraZeneca_Group
|
| gptkbp:products |
Prescription drugs
|
| gptkbp:regulatoryCompliance |
Obtains_regulatory_approvals_in_Japan
|
| gptkbp:research |
Provides research funding
|
| gptkbp:research_areas |
Multiple therapeutic areas
Pioneers therapeutic innovations |
| gptkbp:researchAndDevelopment |
Yes
|
| gptkbp:researchInterest |
Contributes to scientific publications
Engages in research collaboration with universities Adheres to research ethics |
| gptkbp:subsidiary |
gptkb:AstraZeneca
|
| gptkbp:sustainability |
Focuses on sustainable practices
|
| gptkbp:website |
www.astrazeneca.co.jp
|